EULAR 2026… EULAR 2026 Highlights – Metabolic & Crystal Arthropathies 22 Jul 202624 Jul 2026 Treat-to-target continuation of urate-lowering therapy versus a urate-lowering therapy discontinuation attempt strategy in gout patients in remission (go test finale): a pragmatic open label randomised superiority trial Abstract format and…
EULAR 2026… EULAR 2026 Highlights – Rheumatoid Arthritis (therapeutic and non-therapeutic) 22 Jul 202624 Jul 2026 CD19 CAR T-Cell Therapy in ACPA-Positive, Treatment-Refractory, Active Rheumatoid Arthritis - Data from the Phase 1 of the Prospective, Interventional COMPARE Trial Abstract format and assignment number: Oral presentation OP008 …
Tell Me Something Interesting Tell me something interesting: Activities from the Country Liaison Subcommittee 22 Jul 202622 Jul 2026 The Country Liaison Award From Fer Montero The Country Liaison Award is a new EMEUNET initiative aimed at recognising and highlighting the valuable work carried out by Country Liaisons (CLs)…
EULAR Rheumatology open… Winter 2026 Press Review – EULAR Rheumatology Open 18 Jan 202627 Jan 2026 August 2025 to November 2025 Author: Maxime Melchior Patient Perspectives on Glucocorticoid Toxicity in ANCA-Associated Vasculitis Scherbacher et al. (10.1016/j.ero.2025.10.006) examined the subjective burden of glucocorticoid therapy in patients with ANCA-associated…
Press Review… Autumn 2025 Press Review – Arthritis Research & Therapy 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…